News | Clinical Decision Support | April 29, 2015

Gregg W. Stone Appointed to COR Medical Technologies' Senior Editorial Board

Columbia University Medical center physician, professor brings cardiovascular expertise to review of current medical research, conditions and treatments

April 29, 2015 — COR Medical Technologies (COR) announced that Gregg W. Stone, M.D. has been appointed to its Senior Editorial Board. 

Stone is a professor of medicine at Columbia University and the director of cardiovascular research and education for the Center for Interventional Vascular Therapy at the Columbia University Medical Center and New York Presbyterian Hospital in New York City. Stone also serves as the co-director of medical research and education at the Cardiovascular Research Foundation in New York. 

COR’s Senior Editorial Board provides input on current medical research, conditions and treatments. The board reviews conditions and best practice treatments in order to provide instant decision support from the most current, vetted information available to treat cardiovascular conditions.

“We are pleased to have Dr. Stone join the COR Senior Editorial Board,” said Vince Friedewald, M.D., COR founder and CEO.  “His cardiovascular and interventional vascular therapy experience adds great value to our team.”

Stone received his medical degree from the John Hopkins School of Medicine in Baltimore and completed his residency in internal medicine at the New York Hospital – Cornell Medical Center in New York City.  He trained in cardiology at Cedars-Sinai Medical Center in Los Angeles, and in advanced angioplasty at the Mid-America Heart Institute in Kansas City, Missouri. He is board certified by the American Board of Interventional Cardiology, American Board of Cardiovascular Diseases and American Board of Internal Medicine.

“I am honored to join the distinguished group of medical experts who sit on the COR Medical Technologies Senior Editorial Board,” said Stone. “I am excited to share my experience in cardiovascular medicine with the other members.”

COR Medical Technologies offers CORcare, a comprehensive instant decision support system for rapid and accurate diagnosis, treatment and follow-up management of patients with acute and chronic, common and rare diseases involving the cardiovascular system.

For more information: www.cormedtec.com


Related Content

Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...

Home October 29, 2025
Home
News | Cath Lab

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Elixir Medical, a developer of technologies to treat cardiovascular disease, has announced new clinical ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 22, 2025 — Heartflow, Inc. has introduced Heartflow PCI Navigator, the newest addition to the Heartflow One ...

Home October 23, 2025
Home
News | Cath Lab

Oct. 15, 2025 — Stereotaxis recently announced it has obtained CE Mark in Europe and submitted a 510(k) application to ...

Home October 16, 2025
Home
News | Cath Lab

Oct. 7, 2025 — Medtronic has announced the full distribution of the Neuroguard IEP System (Neuroguard) after a ...

Home October 07, 2025
Home
News | Cath Lab

Sept. 22, 2025 — Nicklaus Children's Heart Institute in Miami, Florida, is now offering bedside transcatheter patent ...

Home September 23, 2025
Home
Subscribe Now